MULN vs. APDN, BIAF, NH, RVYL, PAVS, ESGL, WWAC, HLGN, QH, and LDWY
Should you be buying Mullen Automotive stock or one of its competitors? The main competitors of Mullen Automotive include Applied DNA Sciences (APDN), bioAffinity Technologies (BIAF), NantHealth (NH), Ryvyl (RVYL), Paranovus Entertainment Technology (PAVS), ESGL (ESGL), Worldwide Webb Acquisition (WWAC), Heliogen (HLGN), Quhuo (QH), and Lendway (LDWY). These companies are all part of the "business services" industry.
Mullen Automotive vs.
Applied DNA Sciences (NASDAQ:APDN) and Mullen Automotive (NASDAQ:MULN) are both small-cap industrial products companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, community ranking, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.
Applied DNA Sciences has higher revenue and earnings than Mullen Automotive.
Applied DNA Sciences currently has a consensus target price of $1.50, indicating a potential upside of 777.19%. Given Applied DNA Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Applied DNA Sciences is more favorable than Mullen Automotive.
Mullen Automotive has a net margin of 0.00% compared to Applied DNA Sciences' net margin of -203.76%. Mullen Automotive's return on equity of 0.00% beat Applied DNA Sciences' return on equity.
Applied DNA Sciences received 293 more outperform votes than Mullen Automotive when rated by MarketBeat users.
In the previous week, Mullen Automotive had 1 more articles in the media than Applied DNA Sciences. MarketBeat recorded 3 mentions for Mullen Automotive and 2 mentions for Applied DNA Sciences. Applied DNA Sciences' average media sentiment score of 0.66 beat Mullen Automotive's score of 0.25 indicating that Applied DNA Sciences is being referred to more favorably in the media.
Applied DNA Sciences has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, Mullen Automotive has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500.
22.2% of Applied DNA Sciences shares are held by institutional investors. Comparatively, 11.7% of Mullen Automotive shares are held by institutional investors. 0.2% of Applied DNA Sciences shares are held by insiders. Comparatively, 4.6% of Mullen Automotive shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Applied DNA Sciences beats Mullen Automotive on 8 of the 15 factors compared between the two stocks.
Get Mullen Automotive News Delivered to You Automatically
Sign up to receive the latest news and ratings for MULN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mullen Automotive Competitors List
Related Companies and Tools
This page (NASDAQ:MULN) was last updated on 1/23/2025 by MarketBeat.com Staff
